Imagen de Portada

Can appropriate systemic treatment help protect the cornea in patients with rheumatoid arthritis? A multidisciplinary approach to autoimmune ocular involvement

Purpose: To correlate rheumatologic with ophthalmic and laboratory findings in patients with rheumatoid arthritis (RA) to identify what effect these have on development of ocular disease. Methods: This is a cross-sectional study of 172 eyes of 86 patients with RA. Patients were examined by a group o...

Descripción completa

Detalles Bibliográficos
Autores Principales: Amador-Patarroyo, Manuel J, Jalil-Florencia, Emilio, Otero-Marquez, Oscar, Mantilla, Ruben D, Rojas-Villarraga, Adriana, Anaya, Juan-Manuel, Barraquer-Coll, Carmen, Molano-González, Nicolas
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: Lippincott Williams and Wilkins 2018
Materias:
Abatacept
Antimalarial agent
Azathioprine
Corticosteroid
Disease modifying antirheumatic drug
Leflunomide
Methotrexate
Rheumatoid factor
Salazosulfapyridine
Tocilizumab
Tumor necrosis factor inhibitor
Antirheumatic agent
Immunosuppressive agent
Article
Cell count
Cornea
Cornea endothelium
Cross-sectional study
Disease activity score
Disease duration
Eye disease
Eye protection
Female
Human
Keratoconus
Keratometry
Major clinical study
Male
Ophthalmology
Priority journal
Rheumatoid arthritis
Scleritis
Systemic therapy
Tear osmolarity
Adult
Aged
Analysis of variance
Chemistry
Complication
Cornea disease
Cytology
Endothelium cell
Lacrimal fluid
Middle aged
Pathology
Risk factor
Antirheumatic agents
Corneal diseases
Corneal topography
Cross-sectional studies
Endothelial cells
Humans
Immunosuppressive agents
Risk factors
Tears
Collagenolysis
Disease-modifying antirheumatic drugs
rheumatoid
Arthritis
Acceso en línea:https://repository.urosario.edu.co/handle/10336/23778
https://doi.org/10.1097/ICO.0000000000001467

Internet

https://repository.urosario.edu.co/handle/10336/23778
https://doi.org/10.1097/ICO.0000000000001467

Ejemplares similares